Valsartan/hctz 160mg/25mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with or without food, and try to take it at the same time every day. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.
It's essential to note that this medication may increase your urine production. To minimize sleep disturbances, avoid taking your medication too close to bedtime. Additionally, drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of reach of children and pets. When disposing of unused or expired medications, do not flush them down the toilet or pour them down the drain unless instructed to do so. Instead, consult your pharmacist for guidance on proper disposal methods. You may also want to explore local drug take-back programs.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at once or take extra doses to make up for a missed dose.
Lifestyle & Tips
- Take this medication exactly as prescribed, usually once daily with or without food.
- Do not stop taking this medication without talking to your doctor, even if you feel well.
- Continue to follow a low-sodium diet as advised by your doctor or dietitian.
- Engage in regular physical activity and maintain a healthy weight.
- Limit alcohol intake.
- Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor.
- Monitor your blood pressure regularly at home if advised by your doctor.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or passing out
+ Increased thirst
+ Seizures
+ Feeling very tired or weak
+ Decreased appetite
+ Unable to pass urine or change in the amount of urine produced
+ Dry mouth
+ Dry eyes
+ Severe upset stomach or throwing up
Signs of kidney problems, including:
+ Unable to pass urine
+ Change in how much urine is passed
+ Blood in the urine
+ A big weight gain
Swelling in the arms or legs
Eye problems, which can lead to lasting eyesight loss if left untreated. If you experience any of the following symptoms, contact your doctor right away:
+ Change in eyesight
+ Eye pain (usually occurs within hours to weeks of starting this medication)
Rarely, certain types of skin cancer have been reported in people taking hydrochlorothiazide. To minimize your risk:
+ Protect your skin from the sun
+ Have your skin checked as directed by your doctor
+ Contact your doctor immediately if you notice any changes in the color or size of a mole, or any new or changing skin lump or growth
Other Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you're bothered by any of the following:
Dizziness
Headache
Nose or throat irritation
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or fainting (especially when standing up)
- Unusual tiredness or weakness
- Muscle cramps or pain
- Irregular heartbeat
- Swelling of the face, lips, tongue, or throat (signs of angioedema - seek emergency medical attention immediately)
- Decreased urination or swelling in your feet or ankles (signs of kidney problems)
- Yellowing of the skin or eyes (jaundice)
- Persistent cough (less common with ARBs than ACE inhibitors, but possible)
Before Using This Medicine
It is essential to inform your doctor about the following conditions to ensure safe treatment:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
A known sulfa allergy.
Current treatment with dofetilide.
Difficulty urinating or inability to pass urine.
Concurrent use of a medication containing aliskiren, particularly if you have diabetes or kidney problems.
Breast-feeding status, as you should not breast-feed while taking this medication.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health issues. Never start, stop, or adjust the dose of any medication without consulting your doctor first.
Precautions & Cautions
It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Caution with Daily Activities
Until you understand how this medication affects you, avoid driving and engaging in other activities that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position. Be cautious when navigating stairs.
Monitoring Your Condition
If you have diabetes (high blood sugar), closely monitor your blood sugar levels. Check your blood pressure as directed by your healthcare provider. Be aware that this medication may cause increased cholesterol and triglyceride levels. If you already have high cholesterol or triglycerides, discuss this with your doctor.
Lab Tests and Monitoring
Your doctor will schedule regular blood work and other lab tests to monitor your condition. Inform all healthcare providers and lab personnel that you are taking this medication, as it may affect certain lab test results.
Potential Interactions and Effects
It may take several weeks to experience the full effects of this medication. If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.
Over-the-Counter (OTC) Products and Substances
Before using OTC products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult your doctor. Additionally, discuss the use of alcohol, marijuana or other cannabis products, or prescription/OTC medications that may cause drowsiness with your doctor.
Heat and Fluid Loss
Be cautious in hot weather or during physical activity, and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these symptoms may lead to low blood pressure.
Interactions with Other Medications
If you take cholestyramine or colestipol, consult your pharmacist about how to take these medications with this drug. Be aware of the potential for gout attacks.
Lupus Considerations
If you have lupus, this medication may cause your condition to become active or worsen. Immediately inform your doctor if you experience any new or worsening symptoms.
Overdose Information
Overdose Symptoms:
- Severe hypotension (low blood pressure)
- Dizziness
- Fainting
- Tachycardia (rapid heart rate)
- Bradycardia (slow heart rate)
- Electrolyte disturbances (e.g., hypokalemia, hyponatremia)
- Dehydration
What to Do:
Seek emergency medical attention or call Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic. Induce emesis or perform gastric lavage if ingestion is recent. Administer activated charcoal. Correct hypotension with IV fluids. Monitor vital signs and electrolytes closely.
Drug Interactions
Contraindicated Interactions
- Aliskiren (in patients with diabetes or renal impairment (GFR <60 mL/min/1.73 m²))
Major Interactions
- Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
- Potassium supplements or salt substitutes containing potassium
- Lithium (increased serum lithium concentrations and toxicity)
- Non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (may reduce antihypertensive effect and increase risk of renal impairment)
- Other antihypertensive agents (additive hypotensive effect)
- Drugs that increase serum potassium (e.g., trimethoprim, cyclosporine, heparin)
Moderate Interactions
- Bile acid sequestrants (e.g., cholestyramine, colestipol - may reduce absorption of HCTZ)
- Corticosteroids, ACTH (may intensify electrolyte depletion, particularly hypokalemia)
- Antidiabetic agents (oral agents and insulin - HCTZ may decrease glucose tolerance)
- Digitalis glycosides (hypokalemia/hypomagnesemia induced by HCTZ may predispose to digitalis toxicity)
- Muscle relaxants, non-depolarizing (e.g., tubocurarine - HCTZ may potentiate their effect)
- Pressor amines (e.g., norepinephrine - HCTZ may decrease arterial responsiveness)
Minor Interactions
- Alcohol, barbiturates, or narcotics (may potentiate orthostatic hypotension)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and assess efficacy.
Timing: Prior to initiation
Rationale: To establish baseline and identify pre-existing imbalances; HCTZ can cause hypokalemia, hyponatremia, hypomagnesemia, and hypercalcemia; Valsartan can cause hyperkalemia.
Timing: Prior to initiation
Rationale: To assess baseline kidney function, as both components are renally cleared and can affect renal function, especially in susceptible patients.
Timing: Prior to initiation
Rationale: To assess baseline hepatic function, as valsartan is metabolized in the liver and HCTZ should be used with caution in hepatic impairment.
Timing: Prior to initiation
Rationale: HCTZ can increase uric acid levels, potentially precipitating gout.
Timing: Prior to initiation
Rationale: HCTZ can cause hyperglycemia.
Timing: Prior to initiation
Routine Monitoring
Frequency: Regularly (e.g., weekly after initiation/dose change, then monthly/quarterly)
Target: <130/80 mmHg (individualized based on guidelines and patient comorbidities)
Action Threshold: Persistent elevation above target or symptomatic hypotension
Frequency: 1-2 weeks after initiation/dose change, then periodically (e.g., every 3-6 months) or as clinically indicated.
Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L
Action Threshold: Potassium <3.0 or >5.5 mEq/L; Sodium <130 or >150 mEq/L, or symptomatic changes
Frequency: 1-2 weeks after initiation/dose change, then periodically (e.g., every 3-6 months) or as clinically indicated, especially in patients with pre-existing renal impairment or those on concomitant nephrotoxic drugs.
Target: Stable within patient's baseline range
Action Threshold: Significant increase in creatinine (>30% from baseline) or decrease in eGFR
Frequency: Periodically, especially in diabetic patients or those at risk for diabetes.
Target: Individualized based on patient's diabetic status
Action Threshold: Significant increase in blood glucose
Frequency: Periodically, especially in patients with a history of gout or hyperuricemia.
Target: Within normal limits
Action Threshold: Significant increase or symptoms of gout
Symptom Monitoring
- Dizziness
- Lightheadedness
- Fatigue
- Muscle cramps or weakness (signs of electrolyte imbalance)
- Excessive thirst or dry mouth (signs of dehydration)
- Swelling of face, lips, tongue, or throat (signs of angioedema - rare but serious)
- Signs of gout (joint pain, swelling, redness)
- Signs of hyperglycemia (increased thirst, urination, fatigue)
Special Patient Groups
Pregnancy
Contraindicated in the second and third trimesters of pregnancy due to the risk of fetal injury and death (renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death). Discontinue as soon as pregnancy is detected. Use in the first trimester is generally avoided due to potential risks, though less severe than later trimesters.
Trimester-Specific Risks:
Lactation
Not recommended. Both valsartan and hydrochlorothiazide are excreted in human milk. Hydrochlorothiazide can suppress lactation. Due to the potential for serious adverse effects in the breastfed infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.
Geriatric Use
No overall differences in effectiveness or safety have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Start with lower doses and monitor renal function and electrolytes closely, as elderly patients are more likely to have impaired renal function and be on concomitant medications.
Clinical Information
Clinical Pearls
- Valsartan/HCTZ is a fixed-dose combination and should not be used as initial therapy for hypertension unless the patient has already been titrated to the individual components.
- Monitor for signs of angioedema, though rare with ARBs, it is a serious adverse effect.
- Patients should be advised to report any symptoms of electrolyte imbalance (e.g., muscle cramps, weakness, irregular heartbeats).
- Caution is advised when co-administering with NSAIDs due to increased risk of renal impairment and reduced antihypertensive effect.
- Avoid in patients with anuria or severe renal impairment (CrCl <30 mL/min).
- Patients with a history of gout should be monitored closely for increased uric acid levels.
Alternative Therapies
- Other classes of antihypertensives (e.g., ACE inhibitors, calcium channel blockers, beta-blockers, loop diuretics, alpha-blockers)
- Monotherapy with valsartan or hydrochlorothiazide if combination is not needed or tolerated.